These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 25129403)

  • 1. Elevated levels of Th17 cells and Th17-related cytokines are associated with disease activity in patients with inflammatory bowel disease.
    Jiang W; Su J; Zhang X; Cheng X; Zhou J; Shi R; Zhang H
    Inflamm Res; 2014 Nov; 63(11):943-50. PubMed ID: 25129403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal Immunity Related to FOXP3
    Cho J; Kim S; Yang DH; Lee J; Park KW; Go J; Hyun CL; Jee Y; Kang KS
    J Korean Med Sci; 2018 Dec; 33(52):e336. PubMed ID: 30584414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-α and Modulated by IL23R Genotype Status.
    Stallhofer J; Friedrich M; Konrad-Zerna A; Wetzke M; Lohse P; Glas J; Tillack-Schreiber C; Schnitzler F; Beigel F; Brand S
    Inflamm Bowel Dis; 2015 Oct; 21(10):2327-40. PubMed ID: 26263469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
    Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA
    Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
    Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
    Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crossover Subsets of CD4
    Li J; Ueno A; Iacucci M; Fort Gasia M; Jijon HB; Panaccione R; Kaplan GG; Beck PL; Luider J; Barkema HW; Qian J; Gui X; Ghosh S
    Dig Dis Sci; 2017 Sep; 62(9):2357-2368. PubMed ID: 28573508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases.
    Hovhannisyan Z; Treatman J; Littman DR; Mayer L
    Gastroenterology; 2011 Mar; 140(3):957-65. PubMed ID: 21147109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Pathogenic Th17 Profile in Mesenteric Lymph Nodes of Crohn's Disease and Ulcerative Colitis Patients.
    Bsat M; Chapuy L; Rubio M; Wassef R; Richard C; Schwenter F; Loungnarath R; Soucy G; Mehta H; Sarfati M
    Front Immunol; 2019; 10():1177. PubMed ID: 31191543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease.
    Shen W; Durum SK
    Neurochem Res; 2010 Jun; 35(6):940-6. PubMed ID: 19915978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease.
    Sugihara T; Kobori A; Imaeda H; Tsujikawa T; Amagase K; Takeuchi K; Fujiyama Y; Andoh A
    Clin Exp Immunol; 2010 Jun; 160(3):386-93. PubMed ID: 20089077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases.
    Serriari NE; Eoche M; Lamotte L; Lion J; Fumery M; Marcelo P; Chatelain D; Barre A; Nguyen-Khac E; Lantz O; Dupas JL; Treiner E
    Clin Exp Immunol; 2014 May; 176(2):266-74. PubMed ID: 24450998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease.
    Mitsialis V; Wall S; Liu P; Ordovas-Montanes J; Parmet T; Vukovic M; Spencer D; Field M; McCourt C; Toothaker J; Bousvaros A; ; ; Shalek AK; Kean L; Horwitz B; Goldsmith J; Tseng G; Snapper SB; Konnikova L
    Gastroenterology; 2020 Aug; 159(2):591-608.e10. PubMed ID: 32428507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients.
    Ueno A; Jijon H; Chan R; Ford K; Hirota C; Kaplan GG; Beck PL; Iacucci M; Fort Gasia M; Barkema HW; Panaccione R; Ghosh S
    Inflamm Bowel Dis; 2013 Nov; 19(12):2522-34. PubMed ID: 24097227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathological Features of Inflammatory Bowel Disease are Associated With Different CD4+ T Cell Subsets in Colonic Mucosal Lamina Propria.
    Gui X; Li J; Ueno A; Iacucci M; Qian J; Ghosh S
    J Crohns Colitis; 2018 Nov; 12(12):1448-1458. PubMed ID: 30137280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
    Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
    Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lnc-ITSN1-2, Derived From RNA Sequencing, Correlates With Increased Disease Risk, Activity and Promotes CD4
    Nie J; Zhao Q
    Front Immunol; 2020; 11():852. PubMed ID: 32547537
    [No Abstract]   [Full Text] [Related]  

  • 17. The possible role of the novel cytokines il-35 and il-37 in inflammatory bowel disease.
    Li Y; Wang Y; Liu Y; Wang Y; Zuo X; Li Y; Lu X
    Mediators Inflamm; 2014; 2014():136329. PubMed ID: 25214710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of interleukin 17 in inflammatory bowel disease.
    Fujino S; Andoh A; Bamba S; Ogawa A; Hata K; Araki Y; Bamba T; Fujiyama Y
    Gut; 2003 Jan; 52(1):65-70. PubMed ID: 12477762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of interleukin-12 and -17 in active inflammatory bowel disease.
    Nielsen OH; Kirman I; Rüdiger N; Hendel J; Vainer B
    Scand J Gastroenterol; 2003 Feb; 38(2):180-5. PubMed ID: 12678335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of circulating Th17 cells in quiescent versus active Crohn's disease.
    Dige A; Støy S; Rasmussen TK; Kelsen J; Hvas CL; Sandahl TD; Dahlerup JF; Deleuran B; Agnholt J
    J Crohns Colitis; 2013 Apr; 7(3):248-55. PubMed ID: 22784949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.